Literature DB >> 17484225

Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome.

Matthew S Wilder1, Lawrence A Palinkas, Annie S Kao, John F Bastian, Christena L Turner, Jane C Burns.   

Abstract

BACKGROUND: A diagnosis of Kawasaki syndrome is based on clinical criteria with nonspecific laboratory findings, and there is a substantial risk of coronary artery aneurysms if treatment with intravenous immunoglobulin is delayed. In this study, we examined the contributions of sociodemographic factors and parent and physician behavior to the development of coronary artery aneurysms in children with Kawasaki syndrome.
METHODS: We performed a retrospective, case-control chart review of Kawasaki syndrome patients treated at our institution during an 11-year period (1991-2002). Of 324 patients, 21 patients had coronary artery aneurysms and were matched with 81 Kawasaki syndrome control patients without coronary artery aneurysms.
RESULTS: Patients who developed coronary artery aneurysms were more likely to have had their diagnosis established after 10 days of fever as a result of a delay in physician recognition of Kawasaki syndrome. In addition, these patients were also more likely to have been hospitalized at an outside facility with an erroneous diagnosis, to have had a greater number of healthcare visits before diagnosis, to have sought medical care in Mexico, to lack medical insurance and to speak Spanish as a primary language. Independent predictors of delayed diagnosis included incomplete clinical signs of Kawasaki syndrome, seeking health care in Mexico, and being hospitalized at an outside facility with a different diagnosis.
CONCLUSIONS: Increased risk of coronary artery aneurysms is associated with a delay in diagnosis by physicians and not with a delay in seeking medical consultation by parents. Sociodemographic factors influence the likelihood that patients will have a delayed diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17484225      PMCID: PMC2868827          DOI: 10.1097/01.inf.0000256783.57041.66

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998.

Authors:  D E Bronstein; A N Dille; J P Austin; C M Williams; L A Palinkas; J C Burns
Journal:  Pediatr Infect Dis J       Date:  2000-11       Impact factor: 2.129

2.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

3.  Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research.

Authors:  A Kleinman; L Eisenberg; B Good
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

4.  Delayed diagnosis of Kawasaki syndrome: an analysis of the problem.

Authors:  Marsha S Anderson; James K Todd; Mary P Glodé
Journal:  Pediatrics       Date:  2005-04       Impact factor: 7.124

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

6.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

7.  Varieties of health services utilization by underserved Mexican American women.

Authors:  Esmeralda Iniguez; Lawrence A Palinkas
Journal:  J Health Care Poor Underserved       Date:  2003-02

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

9.  Epidemiologic aspects of Kawasaki disease in a Manhattan hospital.

Authors:  F Ichida; N S Fatica; J E O'Loughlin; A A Klein; M S Snyder; A R Levin; K H Ehlers; M L Lesser; M A Engle
Journal:  Pediatrics       Date:  1989-08       Impact factor: 7.124

10.  Kawasaki syndrome: description of two outbreaks in the United States.

Authors:  D M Bell; E W Brink; J L Nitzkin; C B Hall; H Wulff; I D Berkowitz; P M Feorino; R C Holman; C L Huntley; R H Meade; L J Anderson; S H Cheeseman; N J Fiumara; R F Gilfillan; D E Keim; J F Modlin
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

  10 in total
  22 in total

1.  Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Makiko Naka Mieno; Ritei Uehara; Keiji Tsuchiya; Tomoyoshi Sonobe; Yosikazu Nakamura
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

2.  Complete and incomplete Kawasaki disease: two sides of the same coin.

Authors:  Cedric Manlhiot; Erin Christie; Brian W McCrindle; Hans Rosenberg; Nita Chahal; Rae S M Yeung
Journal:  Eur J Pediatr       Date:  2011-12-03       Impact factor: 3.183

3.  Recurrent fever syndromes in patients after recovery from Kawasaki syndrome.

Authors:  Lori Broderick; Adriana H Tremoulet; Jane C Burns; John F Bastian; Hal M Hoffman
Journal:  Pediatrics       Date:  2011-01-10       Impact factor: 7.124

4.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

5.  Spatial and temporal clustering of Kawasaki syndrome cases.

Authors:  Annie S Kao; Arthur Getis; Stephanie Brodine; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2008-11       Impact factor: 2.129

6.  Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease.

Authors:  Dibyendu Sengupta; Andrew M Kahn; Ethan Kung; Mahdi Esmaily Moghadam; Olga Shirinsky; Galina A Lyskina; Jane C Burns; Alison L Marsden
Journal:  Biomech Model Mechanobiol       Date:  2014-04-11

7.  Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection.

Authors:  Stephen J Popper; Virginia E Watson; Chisato Shimizu; John T Kanegaye; Jane C Burns; David A Relman
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

8.  Kawasaki disease recognition and treatment.

Authors:  Kimberly A Morishita; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-08       Impact factor: 3.275

9.  Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes.

Authors:  Son Doan; Cleo K Maehara; Juan D Chaparro; Sisi Lu; Ruiling Liu; Amanda Graham; Erika Berry; Chun-Nan Hsu; John T Kanegaye; David D Lloyd; Lucila Ohno-Machado; Jane C Burns; Adriana H Tremoulet
Journal:  Acad Emerg Med       Date:  2016-04-13       Impact factor: 3.451

10.  Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Authors:  Elizabeth S Yellen; Kimberlee Gauvreau; Masato Takahashi; Jane C Burns; Stanford Shulman; Annette L Baker; Nancy Innocentini; Chiara Zambetti; Joan M Pancheri; Adam Ostrow; Jeffrey R Frazer; Robert P Sundel; David R Fulton; Jane W Newburger
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.